tiprankstipranks
Trending News
More News >
Aspen Aerogels (ASPN)
NYSE:ASPN
Advertisement

Aspen Aerogels (ASPN) AI Stock Analysis

Compare
1,236 Followers

Top Page

ASPN

Aspen Aerogels

(NYSE:ASPN)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 4o)
Rating:42Neutral
Price Target:
$4.00
▲(3.63% Upside)
Aspen Aerogels' overall stock score is primarily impacted by its financial performance and technical analysis. The company's strong revenue growth is overshadowed by significant profitability and cash flow challenges. Technical indicators point to bearish momentum, and valuation metrics are weak due to ongoing losses. While the earnings call provided some positive future prospects, the immediate financial challenges remain a concern.
Positive Factors
Energy Industrial Segment Growth
The anticipated growth in the Energy Industrial segment indicates a positive trajectory, potentially increasing revenue and market share in 2026.
New Leadership
The addition of experienced leadership can enhance strategic direction and operational efficiency, potentially improving financial performance.
Battery Energy Storage Systems Opportunity
Expanding into battery energy storage systems could diversify revenue streams and leverage Aspen's technology in a growing market.
Negative Factors
Profitability Challenges
Ongoing profitability issues, with negative net profit and EBIT margins, threaten long-term sustainability and financial health.
Cash Flow Issues
Weak cash flow limits the company's ability to invest in growth opportunities and meet financial obligations, impacting future stability.
Uncertain EV Market Conditions
Uncertainty in the EV market affects Aspen's revenue projections and operational planning, posing risks to growth and profitability.

Aspen Aerogels (ASPN) vs. SPDR S&P 500 ETF (SPY)

Aspen Aerogels Business Overview & Revenue Model

Company DescriptionAspen Aerogels, Inc. is a leading provider of advanced aerogel solutions, focusing on enhancing energy efficiency and performance across various industries. The company specializes in the development and production of aerogel insulation products, which are used primarily in the oil and gas, industrial, and building sectors. Aspen Aerogels offers a range of high-performance insulation materials that are designed to reduce energy consumption and improve operational efficiency in demanding environments.
How the Company Makes MoneyAspen Aerogels generates revenue primarily through the sale of its aerogel insulation products to a diverse customer base in the oil and gas, industrial, and construction sectors. The company’s revenue model is built on direct sales, contracts with large industrial clients, and partnerships with distributors. Key revenue streams include high-performance insulation for pipelines, equipment, and buildings, which are critical for energy conservation and cost savings. Additionally, Aspen Aerogels may engage in research and development collaborations and strategic partnerships that enhance product innovation and market reach, contributing to its overall earnings.

Aspen Aerogels Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where the company is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsAspen Aerogels is experiencing robust revenue growth in the United States and Latin America, driven by strategic initiatives like the GM PyroThin award and supply chain diversification. However, Asia's revenue is declining, possibly due to market saturation or competitive pressures. Despite a 17% year-over-year revenue decline, the company is focusing on cost optimization and new OEM opportunities, setting the stage for potential long-term growth. The earnings call highlights strategic achievements but also underscores immediate financial challenges, such as declining gross margins and net income losses.
Data provided by:Main Street Data

Aspen Aerogels Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 12, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a challenging quarter for Aspen Aerogels, with declining revenue and profitability primarily due to EV market uncertainties. However, positive developments in leadership, potential growth in the European market, and emerging opportunities in energy industrial and storage systems provide some optimism for future growth.
Q3-2025 Updates
Positive Updates
Introduction of New Leadership
Aspen Aerogels introduced two key additions to its leadership team: Grant Thoele as CFO and Glenn Deegan as Chief Administrative Officer, bringing significant operational, transactional, and integration experience.
Design Award from European OEM
Aspen won a battery design award from a major European OEM, expected to ramp in 2027, demonstrating potential growth in the European market.
Energy Industrial Segment Growth
The Energy Industrial segment is stabilizing and expected to grow in 2026 with substantial subsea project revenue and a return to robust sales, indicating a positive trajectory.
Battery Energy Storage Systems Opportunity
Shifting to higher-density LFP designs in grid-scale storage presents a new opportunity for Aspen's PyroThin thermal barrier technology, with potential contributions to revenue in 2026.
Negative Updates
Decline in Q3 Revenue and Gross Profit
Q3 revenue declined by 6% to $73 million, and gross profit decreased by 18% due to lower EV volumes and less volume to absorb fixed costs.
Uncertain EV Market Conditions
GM and other OEMs are recalibrating production due to market demand, leading to significant uncertainty and a downward revision of Aspen's outlook for Q4 2025.
Negative Adjusted EBITDA Expected in Q4
Aspen projects Q4 adjusted EBITDA to range between negative $14 million to negative $6 million due to regulatory changes affecting EV production.
Financial Challenges and Covenant Relief
Aspen is engaging with lenders for covenant relief due to lower expected full-year results and impacts on liquidity, highlighting financial challenges.
Company Guidance
During Aspen Aerogels' Q3 2025 earnings call, management provided guidance for Q4 and the fiscal year, highlighting several key metrics. They projected Q4 revenue between $40 million to $50 million, with an anticipated mix of approximately $25 million from the Energy Industrial segment. Fiscal year 2025 revenue was expected to range from $270 million to $280 million, with adjusted EBITDA between $7 million to $15 million. The company noted a decline in Q3 revenue to $73 million, down 6% from the previous quarter, with a gross margin decrease to 28.5% from 32.4%. They also highlighted a focus on streamlining operations to achieve adjusted EBITDA breakeven at approximately $200 million in annual revenue. Looking forward, Aspen anticipates a strong growth year in 2026 for the Energy Industrial segment, with potential subsea project revenue of $15 million to $20 million and a supply agreement for the Venture Global CP2 LNG project. Additionally, Aspen is targeting new opportunities in battery energy storage systems, which could contribute significantly to 2026 revenues.

Aspen Aerogels Financial Statement Overview

Summary
Aspen Aerogels shows strong revenue growth, but faces significant challenges in profitability and cash flow management. The negative net profit, EBIT margins, and cash flow issues highlight operational inefficiencies and risks to long-term sustainability.
Income Statement
45
Neutral
Aspen Aerogels shows significant revenue growth in the TTM period, with a remarkable increase of over 18,000%. However, profitability remains a challenge, as indicated by negative net profit and EBIT margins. The gross profit margin has improved compared to previous years, but the company still struggles with negative EBITDA and EBIT margins, reflecting operational inefficiencies.
Balance Sheet
55
Neutral
The company's balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the return on equity is negative, suggesting that the company is not generating sufficient returns on its equity base. The equity ratio is stable, but the negative ROE highlights profitability concerns.
Cash Flow
40
Negative
Aspen Aerogels faces challenges in cash flow management, with negative free cash flow growth and low operating cash flow coverage. The operating cash flow to net income ratio is extremely low, indicating cash flow issues. Despite a slight improvement in free cash flow to net income ratio, the overall cash flow position remains weak.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue352.85M452.70M238.72M180.36M121.62M100.27M
Gross Profit116.06M182.90M56.92M4.98M9.94M14.59M
EBITDA-274.98M51.46M-22.31M-65.77M-25.81M-11.37M
Net Income-305.28M13.38M-45.81M-86.23M-27.88M-11.85M
Balance Sheet
Total Assets491.39M895.14M703.05M646.57M182.95M97.42M
Cash, Cash Equivalents and Short-Term Investments150.72M220.88M139.72M281.33M76.56M16.50M
Total Debt80.06M197.38M138.77M126.66M15.24M8.31M
Total Liabilities185.66M280.44M214.99M203.23M54.55M29.57M
Stockholders Equity305.73M614.71M488.06M447.44M128.41M67.85M
Cash Flow
Free Cash Flow2.69M-40.71M-218.07M-272.37M-32.41M-13.34M
Operating Cash Flow52.42M45.55M-42.61M-94.40M-18.63M-9.92M
Investing Cash Flow-49.74M-86.26M-175.46M-177.97M-13.78M-3.42M
Financing Cash Flow35.86M122.02M75.48M478.37M92.47M26.20M

Aspen Aerogels Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.86
Price Trends
50DMA
7.30
Negative
100DMA
7.14
Negative
200DMA
7.13
Negative
Market Momentum
MACD
-0.54
Positive
RSI
25.49
Positive
STOCH
7.10
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASPN, the sentiment is Negative. The current price of 3.86 is below the 20-day moving average (MA) of 7.62, below the 50-day MA of 7.30, and below the 200-day MA of 7.13, indicating a bearish trend. The MACD of -0.54 indicates Positive momentum. The RSI at 25.49 is Positive, neither overbought nor oversold. The STOCH value of 7.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASPN.

Aspen Aerogels Risk Analysis

Aspen Aerogels disclosed 72 risk factors in its most recent earnings report. Aspen Aerogels reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aspen Aerogels Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$225.58M22.3313.51%14.90%-34.75%
66
Neutral
$1.76B831.6213.29%-9.21%-97.43%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
62
Neutral
$503.38M18.872.20%-0.19%-50.51%
61
Neutral
$743.63M16.948.83%3.02%1.19%-56.98%
50
Neutral
$613.83M-43.35%2.46%70.18%-374.22%
42
Neutral
$610.29M-75.06%-14.74%-20086.56%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASPN
Aspen Aerogels
3.86
-12.63
-76.59%
APOG
Apogee
34.44
-49.54
-58.99%
BXC
Bluelinx Holdings
60.69
-61.57
-50.36%
ROCK
Gibraltar Industries
61.54
-11.58
-15.84%
PPIH
Perma-Pipe International Holdings
27.80
13.49
94.27%
NX
Quanex
13.06
-16.95
-56.48%

Aspen Aerogels Corporate Events

Aspen Aerogels Reports Q3 2025 Financial Results
Nov 7, 2025

Aspen Aerogels, Inc. is a technology leader in sustainability and electrification solutions, specializing in aerogel technology that supports resource efficiency, e-mobility, and clean energy. The company recently announced its third-quarter 2025 financial results, highlighting a significant decrease in revenue and a narrowed net loss compared to the previous year. Aspen Aerogels reported a total revenue of $73 million for the third quarter of 2025, down from $117.3 million in the same period of 2024. The net loss for the quarter was $6.3 million, an improvement from the $13 million loss in the third quarter of 2024. Adjusted EBITDA also saw a decline to $6.3 million from $25.4 million year-over-year. Key highlights include a PyroThin® Thermal Barrier contract from a major European OEM and anticipated growth in the Energy Industrial sector driven by LNG and Subsea projects in 2026. Despite a challenging environment in the U.S. EV market, Aspen Aerogels remains focused on rebuilding growth in its Thermal Barrier business and diversifying into adjacent markets. The company has updated its full-year 2025 outlook to reflect lower near-term EV production in North America, with revenue now expected to range between $270 million and $280 million. Aspen Aerogels aims to drive growth through innovation and strategic partnerships while maintaining a capital-efficient business model.

Aspen Aerogels Navigates Market Challenges with Optimism
Nov 7, 2025

Aspen Aerogels Faces Challenges Amidst Market Uncertainties

Business Operations and StrategyFinancial Disclosures
Aspen Aerogels Reports Q3 2025 Revenue Decline
Negative
Nov 6, 2025

Aspen Aerogels reported a decrease in total revenue to $73.0 million for Q3 2025, down from $117.3 million in Q3 2024, alongside a reduced net loss of $6.3 million compared to $13.0 million the previous year. The company updated its 2025 outlook to reflect lower demand in the U.S. EV market, while highlighting growth opportunities in its Energy Industrial segment for 2026 and a significant PyroThin® contract with a European OEM. Aspen is focusing on cost reduction and operational efficiency to stabilize and grow its business amid market challenges.

The most recent analyst rating on (ASPN) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Aspen Aerogels stock, see the ASPN Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Aspen Aerogels Appoints New CFO Grant Thoele
Neutral
Sep 11, 2025

Aspen Aerogels announced the promotion of Grant Thoele to Chief Financial Officer and Treasurer, effective October 1, 2025, succeeding Ricardo C. Rodriguez. The employment agreement outlines Thoele’s compensation, including a base salary of $390,000, performance-based bonuses, and equity grants. The agreement also details conditions for termination benefits and includes restrictive covenants on confidentiality and non-competition, highlighting the company’s strategic focus on leadership continuity and operational stability.

The most recent analyst rating on (ASPN) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Aspen Aerogels stock, see the ASPN Stock Forecast page.

Aspen Aerogels’ Strategic Moves Amid Market Challenges
Aug 13, 2025

Aspen Aerogels Navigates Challenging Market with Strategic Optimism

Aspen Aerogels Reports Q2 2025 Financial Results
Aug 8, 2025

Aspen Aerogels, Inc. is a technology leader in sustainability and electrification solutions, known for its aerogel technology that supports resource efficiency, e-mobility, and clean energy initiatives. The company recently reported its second quarter 2025 financial results, highlighting a revenue of $78 million and a gross margin of 32%. Despite a net loss of $9.1 million, the company showed significant improvement in adjusted EBITDA, which nearly doubled quarter-over-quarter.

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Aspen Aerogels Reports Q2 2025 Financial Results
Neutral
Aug 7, 2025

Aspen Aerogels reported second quarter 2025 financial results, highlighting a revenue of $78 million with a 32% gross margin and a significant improvement in Adjusted EBITDA. Despite a net loss of $9.1 million, the company achieved operational improvements through cost structure optimization and strategic restructuring. The transition of CFO Ricardo Rodriguez to Grant Thoele is expected to ensure continuity in strategic direction, with a focus on maintaining financial resilience amid regulatory and market challenges.

The most recent analyst rating on (ASPN) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on Aspen Aerogels stock, see the ASPN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 07, 2025